MedTrace Logo

Bilateral Dispensing Clinical Trial of Stenfilcon A Against Etafilcon A for Astigmatism

NCT02410824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2017-08-21

Study results available
· View outcomes & findings →

Summary

Bilateral dispensing clinical trial of stenfilcon A against etafilcon A for astigmatism.

Conditions

  • Astigmatism

Interventions

DEVICE

stenfilcon A toric lens

toric contact lens

DEVICE

etafilcon A toric lens

toric contact lens

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Meng C Lin, OD PhD · UC Berkeley Clinical Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02410824 on ClinicalTrials.gov